Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
28.1M
-
Shares change
-
+354K
-
Total reported value, excl. options
-
$1.31B
-
Value change
-
-$1.11M
-
Put/Call ratio
-
36.59
-
Number of buys
-
66
-
Number of sells
-
-114
-
Price
-
$46.29
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2015
215 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2015.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.1M shares
of 835M outstanding shares and own 3.37% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (4.5M shares), AQR CAPITAL MANAGEMENT LLC (3.21M shares), COMMONWEALTH BANK OF AUSTRALIA (2.94M shares), VANGUARD GROUP INC (1.41M shares), VONTOBEL ASSET MANAGEMENT INC (1.34M shares), BlackRock Group LTD (1.23M shares), DIMENSIONAL FUND ADVISORS LP (655K shares), CREDIT SUISSE AG/ (566K shares), ACADIAN ASSET MANAGEMENT LLC (520K shares), and PRINCIPAL FINANCIAL GROUP INC (492K shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.